AVIDITY BIOSCIENCES - Trademark Details
Status: 700 - Registered
Serial Number
88808590
Registration Number
6151953
Word Mark
AVIDITY BIOSCIENCES
Status
700 - Registered
Status Date
2020-09-15
Filing Date
2020-02-24
Registration Number
6151953
Registration Date
2020-09-15
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Typeset
Design Searches
090104, 260728 - Ribbons, bows. Miscellaneous designs with overall diamond shape, including letters forming or comprising a diamond.
Published for Opposition Date
2020-06-30
Attorney Name
Law Office Assigned Location Code
M40
Employee Name
KEELEY, ALISON REBECCA
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Disclaimer with Predetermined Text
"BIOSCIENCES"
Description of Mark
The mark consists of the wording "AVIDITY" in an all-caps font where the "A" is formed by a down-facing angle. The wording "BIOSCIENCES" appears below in a smaller all-caps font. To the left of the wording is a highly stylized design of two curved ribbons forming a diamond or partial double-helix shape.
Goods and Services
Research and development in the pharmaceutical and biotechnology fields, namely, research and development for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; research and development for the use of antibody-oligonucleotide conjugates for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; medical and scientific research services for the use of antibody-oligonucleotide conjugates for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; development of pharmaceutical preparations and medicines, namely, the development of oligonucleotide-based therapeutics
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2020-02-27
Primary Code
042
First Use Anywhere Date
2019-01-00
First Use In Commerce Date
2019-01-00
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Aaron D. Hendelman
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2020-02-27 | NEW APPLICATION ENTERED IN TRAM |
2020-02-27 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2020-02-28 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
2020-05-12 | ASSIGNED TO EXAMINER |
2020-05-20 | NON-FINAL ACTION WRITTEN |
2020-05-20 | NON-FINAL ACTION E-MAILED |
2020-05-20 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2020-05-28 | EXAMINERS AMENDMENT -WRITTEN |
2020-05-28 | EXAMINERS AMENDMENT E-MAILED |
2020-05-28 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
2020-05-28 | EXAMINER'S AMENDMENT ENTERED |
2020-05-28 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2020-05-28 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2020-06-10 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2020-06-30 | PUBLISHED FOR OPPOSITION |
2020-06-30 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2020-09-15 | REGISTERED-PRINCIPAL REGISTER |